Association between systemic immunity-inflammation index and glucose regulation in non-diabetic population: A population-based study from the NHANES (2005–2016)
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0313488 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Wenxiang Qing und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Inflammation, Nutrition Surveys, Blood Glucose, Glucose Tolerance Test. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Background
To investigated the link between the systemic immunity-inflammation index (SII), a new inflammatory biomarker, and the risk of abnormal glucose regulation in non-diabetic population.
Methods
Using data from the 2005–2016 National Health and Nutrition Examination Survey (NHANES), we conducted a cross-sectional study on non-diabetic adults with data on SII and glucose regulation markers. We analyzed the relationship between SII and indicators of glucose regulation, including fasting plasma glucose, fasting insulin, hemoglobin A1c, oral glucose tolerance test (OGTT), and states of abnormal glucose regulation like impaired glucose tolerance (IGT), insulin resistance, and prediabetes.
Results
Adjusting for confounders, higher SII levels were significantly associated with a higher OGTT and a greater likelihood of IGT (OR = 2.673, 95% CI: 1.845, 3.873). In subgroup analysis, participants without hyperlipidemia in the highest SII quartile had a 240% higher odds of IGT compared to those in the lowest quartile (OR = 3.407, 95%CI: 1.995, 5.820), an association not observed in those with hyperlipidemia ( p for interaction < 0.05).
Conclusions
SII emerges as a useful biomarker for identifying IGT in non-diabetic individuals, specifically in those without hyperlipidemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, China.
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China.
ORCID-Profile: Yujie Qian
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Qing, W., & Qian, Y. (2024). Association between systemic immunity-inflammation index and glucose regulation in non-diabetic population: A population-based study from the NHANES (2005–2016). PLOS ONE. https://doi.org/10.1371/journal.pone.0313488
Vancouver
Qing W, Qian Y. Association between systemic immunity-inflammation index and glucose regulation in non-diabetic population: A population-based study from the NHANES (2005–2016). PLOS ONE. 2024. doi:10.1371/journal.pone.0313488
BibTeX
@article{Qing2024,
author = {Qing, Wenxiang and Qian, Yujie},
title = {Association between systemic immunity-inflammation index and glucose regulation in non-diabetic population: A population-based study from the NHANES (2005–2016)},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0313488}
}
EUVIMED